SHR-A2102 binds nectin-4 on tumor cells, is internalized, and releases a topoisomerase-1 inhibitor that blocks DNA replication and induces apoptosis. Topoisomerase I is only the intracellular payload target; its expression alone does not make cells the targets of killing.